Literature DB >> 31588838

Identification of PBMC-expressed miRNAs for rheumatoid arthritis.

Xiaowei Zhu1,2,3, Longfei Wu1,2, Xingbo Mo1,2, Wei Xia1,2, Yufan Guo4, Mingjun Wang4, Keqin Zeng4, Jian Wu4, Yinghua Qiu1,2, Xiang Lin1,2, Xin Lu1,2, Feiyan Deng1,2, Shufeng Lei1,2.   

Abstract

Post-transcriptional regulation by miRNAs plays an important role in the pathogenesis of rheumatoid arthritis (RA), however, the roles of specific miRNAs in RA pathogenesis remain largely unclear. This study performed dual-omics (miRNA and mRNA) integration analysis and in-depth cellular and molecular functional exploration to identify novel RA-associated miRNAs and to understand their underlying pathogenic mechanism. Based on the miRNA and mRNA expression profiles in peripheral blood mononuclear cells (PBMCs) from a discovery sample set (25 RA cases and 18 healthy controls), 18 differentially expressed miRNAs (DEMIRs) (|Fold-change|>2 and P < 0.05) were identified and corresponding interaction networks of DEMIRs and mRNA were constructed. After the expression validation of the DEMIRs in a validation sample set (35 RA cases and 35 healthy controls), miR-99b-5p was highlighted. The over-expression of newly discovered miR-99b-5p is able to suppress T cell apoptosis, promote cell proliferation and activation, increase expression of proinflammatory cytokines (IL-2, IL-6, TNF-α, and IFN-γ), and inhibit expression of its target genes mTOR and RASSF4. This study comprehensively identified PBMC-expressed miRNAs along with corresponding regulatory networks significant for RA and discovered miR-99b-5p as a novel post-transcriptional mediator involved in RA pathogenesis. The findings improved our understanding of RA pathogenesis and provided novel insights into the molecular mechanisms underlying RA pathogenesis.

Entities:  

Keywords:  Rheumatoid arthritis; miR-99b-5p; miRNA

Year:  2019        PMID: 31588838      PMCID: PMC7153549          DOI: 10.1080/15592294.2019.1676613

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  50 in total

Review 1.  Back to the future: oral targeted therapy for RA and other autoimmune diseases.

Authors:  John J O'Shea; Arian Laurence; Iain B McInnes
Journal:  Nat Rev Rheumatol       Date:  2013-02-19       Impact factor: 20.543

2.  Overexpression of miR-595 and miR-1246 in the sera of patients with active forms of inflammatory bowel disease.

Authors:  Geoffrey W Krissansen; Yi Yang; Fiona M McQueen; Euphemia Leung; Deborah Peek; Yih Chih Chan; Cristin Print; Nicola Dalbeth; Megan Williams; Alan G Fraser
Journal:  Inflamm Bowel Dis       Date:  2015-03       Impact factor: 5.325

3.  miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation.

Authors:  Dandan Sun; Yong Sun Lee; Ankit Malhotra; Hak Kyun Kim; Mirela Matecic; Clive Evans; Roderick V Jensen; Christopher A Moskaluk; Anindya Dutta
Journal:  Cancer Res       Date:  2011-01-06       Impact factor: 12.701

4.  mTOR regulates the invasive properties of synovial fibroblasts in rheumatoid arthritis.

Authors:  Teresina Laragione; Pércio S Gulko
Journal:  Mol Med       Date:  2010-05-27       Impact factor: 6.354

Review 5.  New advances of microRNAs in the pathogenesis of rheumatoid arthritis, with a focus on the crosstalk between DNA methylation and the microRNA machinery.

Authors:  Cheng-gui Miao; Ying-ying Yang; Xu He; Tao Xu; Cheng Huang; Yan Huang; Lei Zhang; Xiong-Wen Lv; Yong Jin; Jun Li
Journal:  Cell Signal       Date:  2013-02-04       Impact factor: 4.315

6.  Polymorphisms of COTL1 gene identified by proteomic approach and their association with autoimmune disorders.

Authors:  Eun-Heui Jin; Seung-Cheol Shim; Hwan-Gyu Kim; Soo-Cheon Chae; Hun-Taeg Chung
Journal:  Exp Mol Med       Date:  2009-05-31       Impact factor: 8.718

7.  The clinical significance of PD-L1 in advanced gastric cancer is dependent on ARID1A mutations and ATM expression.

Authors:  Simonetta Buglioni; Elisa Melucci; Francesca Sperati; Matteo Pallocca; Irene Terrenato; Francesca De Nicola; Frauke Goeman; Beatrice Casini; Carla Azzurra Amoreo; Enzo Gallo; Maria Grazia Diodoro; Edoardo Pescarmona; Patrizia Vici; Domenico Sergi; Laura Pizzuti; Luigi Di Lauro; Marco Mazzotta; Maddalena Barba; Maurizio Fanciulli; Ilio Vitale; Ruggero De Maria; Gennaro Ciliberto; Marcello Maugeri-Saccà
Journal:  Oncoimmunology       Date:  2018-04-24       Impact factor: 8.110

8.  Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation.

Authors:  Joanna Stanczyk; Caroline Ospelt; Emmanuel Karouzakis; Andrew Filer; Karim Raza; Christoph Kolling; Renate Gay; Christopher D Buckley; Paul P Tak; Steffen Gay; Diego Kyburz
Journal:  Arthritis Rheum       Date:  2011-02

9.  Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling.

Authors:  Ronald L Chandler; Jeffrey S Damrauer; Jesse R Raab; Jonathan C Schisler; Matthew D Wilkerson; John P Didion; Joshua Starmer; Daniel Serber; Della Yee; Jessie Xiong; David B Darr; Fernando Pardo-Manuel de Villena; William Y Kim; Terry Magnuson
Journal:  Nat Commun       Date:  2015-01-27       Impact factor: 14.919

10.  Infrequently expressed miRNAs influence survival after diagnosis with colorectal cancer.

Authors:  Martha L Slattery; Andrew J Pellatt; Frances Y Lee; Jennifer S Herrick; Wade S Samowitz; John R Stevens; Roger K Wolff; Lila E Mullany
Journal:  Oncotarget       Date:  2017-08-03
View more
  6 in total

Review 1.  Role of microRNA Shuttled in Small Extracellular Vesicles Derived From Mesenchymal Stem/Stromal Cells for Osteoarticular Disease Treatment.

Authors:  Eliana Lara-Barba; María Jesús Araya; Charlotte Nicole Hill; Felipe A Bustamante-Barrientos; Alexander Ortloff; Cynthia García; Felipe Galvez-Jiron; Carolina Pradenas; Noymar Luque-Campos; Gabriela Maita; Roberto Elizondo-Vega; Farida Djouad; Ana María Vega-Letter; Patricia Luz-Crawford
Journal:  Front Immunol       Date:  2021-11-01       Impact factor: 7.561

Review 2.  MicroRNA-Mediated Epigenetic Regulation of Rheumatoid Arthritis Susceptibility and Pathogenesis.

Authors:  Cen Chang; Lingxia Xu; Runrun Zhang; Yehua Jin; Ping Jiang; Kai Wei; Linshuai Xu; Yiming Shi; Jianan Zhao; Momiao Xiong; Shicheng Guo; Dongyi He
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 7.561

3.  Identification of novel rheumatoid arthritis-associated MiRNA-204-5p from plasma exosomes.

Authors:  Long-Fei Wu; Qin Zhang; Xing-Bo Mo; Jun Lin; Yang-Lin Wu; Xin Lu; Pei He; Jian Wu; Yu-Fan Guo; Ming-Jun Wang; Wen-Yan Ren; Hong-Wen Deng; Shu-Feng Lei; Fei-Yan Deng
Journal:  Exp Mol Med       Date:  2022-03-30       Impact factor: 12.153

4.  Dysregulated microRNA expression in rheumatoid arthritis families-a comparison between rheumatoid arthritis patients, their first-degree relatives, and healthy controls.

Authors:  Emma Renman; Mikael Brink; Lisbeth Ärlestig; Solbritt Rantapää-Dahlqvist; Kristina Lejon
Journal:  Clin Rheumatol       Date:  2020-11-18       Impact factor: 2.980

5.  Transcription factor NF-κB promotes acute lung injury via microRNA-99b-mediated PRDM1 down-regulation.

Authors:  Jie Zhao; Fei Xie; Ruidong Chen; Zhen Zhang; Rujun Dai; Na Zhao; Rongxin Wang; Yanhong Sun; Yue Chen
Journal:  J Biol Chem       Date:  2020-10-27       Impact factor: 5.157

6.  Molecular Beacon for Detection miRNA-21 as a Biomarker of Lung Cancer.

Authors:  Daniela Alexandre; Bernardo Teixeira; André Rico; Salete Valente; Ana Craveiro; Pedro V Baptista; Carla Cruz
Journal:  Int J Mol Sci       Date:  2022-03-19       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.